PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Share News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.75
Bid: 10.50
Ask: 11.00
Change: -0.25 (-2.27%)
Spread: 0.50 (4.762%)
Open: 11.00
High: 11.75
Low: 10.75
Prev. Close: 11.00
ABDX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks lower; Sunak looks to sell protocol deal

Tue, 28th Feb 2023 12:03

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday, as investors wait to hear whether UK Prime Minister Rishi Sunak has been able to win support for his Northern Irish border deal with the EU.

The FTSE 100 index was down 27.93 points, 0.4%, at 7,907.18 heading into Tuesday afternoon. The FTSE 250 was down 22.90 points, 0.1%, at 19,863.20, though the AIM All-Share was up 1.07 points, 0.1%, at 859.54.

The Cboe UK 100 was down 0.4% at 791.35, the Cboe UK 250 was up marginally at 17,433.50, and the Cboe Small Companies was down 0.1% at 14,060.42.

Sunak insisted that his new Brexit deal for Northern Ireland addressed the concerns of unionists, despite the "small and limited" role for EU law and its court.

The PM, who was visiting Northern Ireland to sell the deal secured with the EU, said he believed "hand on heart" that it addressed the concerns expressed about the current post-Brexit trading arrangements which triggered the collapse of power-sharing in Stormont.

The Democratic Unionist Party, which brought down the Northern Ireland executive over the measures, is considering its response to the new deal.

The framework removes the Northern Ireland Protocol's barriers on trade across the Irish Sea and hands a "veto" to politicians in Stormont on EU law – a set of concessions from Brussels that went further than some expected.

"While the deal may provide a reset for UK/EU relations and be good for the UK economy, reports suggest some in the DUP are not fully satisfied by what's on the table," said AJ Bell analyst Russ Mould.

Sunak, who is also expected to speak to backbench MPs in England on Tuesday, spoke at length in the Commons on the deal as he sought to see off any threat of rebellion from within his own ranks.

MPs are expected to get a vote on the deal, but Downing Street has not so far said when or how such a vote might take place.

The pound was quoted at USD1.2093 at midday on Tuesday in London, up compared to USD1.2019 at the equities close on Monday. The euro stood at USD1.0611, up against USD1.0591. Against the yen, the dollar was trading at JPY136.72, up compared to JPY136.24.

UK Bank of England Monetary Policy Committee member Catherine Mann and Chief Economist Huw Pill will each speak at around 1230 GMT.

On the LSE, Ocado hurt the FTSE 100 index, slumping 8.3%.

The online grocer and warehouse technology firm said group revenue edged up just 0.6% to GBP2.51 billion in the year ended November 27. All segments saw growth, except for retail - its joint venture with Marks & Spencer - which fell 3.8%. "Robust" customer growth in retail was offset by lower value baskets, the firm said.

Ocado's pretax loss widened to GBP500.8 million from GBP176.9 million. No dividend was declared, unchanged from a year before.

Looking ahead, Ocado expects Retail growth in the mid-single digits for 2023, with Technology to see around 40% Ocado Smart Platform fee revenue growth, and UK Logistics to be "broadly stable".

AJ Bell's Mould said: "The latest results are as appetising as a bucket of sick. Revenue growth has ground to a halt, pretax losses are getting worse and net debt has ballooned.

"Ocado has long argued that it needs to spend money to make money, but patience is wearing thin for the long-suffering shareholders."

However, the firm's grocery market share improved to 1.9% from 1.8% in the 12 weeks to February 19, according to the latest Kantar survey. Ocado sales grew by 11% on-year.

Grocery inflation hit a record of 17.1% in the four weeks to February 19, according to Kantar. This means the average UK household is likely to see an GBP811 increase to their annual bill if inflation continues at the same pace.

Croda International also hurt the FTSE 100, shedding 4.4%.

The Yorkshire, England-based chemicals maker said sales rose 11% year-on-year to GBP2.09 billion in 2022 from GBP1.89 billion a year earlier. Constant currency sales rose by 5.0%, driven by "its ability to recover input cost inflation, with price/mix up by 24%."

Pretax profit surged 90% to GBP780.0 million from GBP411.5 million, as basic earnings per share jumped to 465.8 pence from 230.0p a year ago.

Croda lifted its annual dividend by 8.0% to 108.0 pence per share from 100.0p a year prior.

Looking to 2023, it is trading in line with expectations, and expects destocking to end during the first half. It said it expects its performance to be weighted towards the second half, putting pressure on its future performance.

"Investors hate hearing that phrase as it raises the chances of a profit warning if that six-month period doesn't live up to expectations," Mould added.

In the FTSE 250, Man Group gained 7.9%.

The London-based hedge fund manager said pretax profit in 2022 jumped 25% to USD608 million from USD487 million in 2021. Assets under management fell 3.6% to USD143.3 billion from USD148.6 billion, however.

The company declared a 2022 dividend of 15.7 cents, up 12% from 14.0 a year prior.

Meanwhile, Chair John Cryan will retire from the board "towards the end of 2023". Non-Executive Director Anne Wade will replace Cryan after his departure.

On London's AIM market, Abingdon Health gained 26%.

The developer and manufacturer of rapid diagnostics tests said it expects revenue to increase significantly in its second half, with annual revenue to improve from GBP2.8 million in financial 2022.

Revenue for the six months to December came in at GBP1.1 million, down from GBP1.7 million.

"The company has successfully transitioned its activities away from Covid-19 and is now operating as a fully integrated [contract development & manufacturing organisation] maintaining its full focus on lateral flow testing," the firm explained.

Safestay also jumped 26%.

The hostel owner and operator said annual revenue in 2022 will come in ahead of market expectations at GBP19.0 million, up from GBP6.4 million in 2021. Adjusted earnings before interest, tax, depreciation and amortisation are expected to be in line with market expectations at GBP5.9 million, swinging from a GBP1.0 million loss.

It said business is "returning to normal" with guests being predominantly young travellers, as group bookings are seeing a slower recovery. Average bed rate increases to GBP23.70 from GBP19.70, which should be "sustainable", the firm noted.

In European equities on Tuesday, the CAC 40 in Paris was flat, while the DAX 40 in Frankfurt was up 0.1%.

Growth in the French economy slowed in the final quarter of 2022, final data released on Tuesday confirmed, but it avoided contraction.

According to Insee - France's national statistics body - gross domestic product in the fourth quarter grew by 0.1% from the third quarter. In the third quarter, it had grown by 0.2% from the second.

Insee also released preliminary data for consumer prices.

In February 2023, consumer prices should increase by 6.2% year-on-year, quickening from growth of 6.0% in January.

Also putting the European Central Bank under the spotlight, figures showed inflation in Spain also intensified in February, suggesting that price pressure is proving stickier than ideal.

According to INE, the yearly inflation rate in Spain quickened to 6.1% in February, from 5.9% in January.

Stocks in New York were called lower. The Dow Jones Industrial Average, the S&P 500 index, and the Nasdaq Composite were all called down 0.2%.

Brent oil was quoted at USD83.11 a barrel at midday in London on Tuesday, up from USD82.28 late Monday. Gold was quoted at USD1,810.53 an ounce, down against USD1,816.96.

Still to come in Tuesday's economic calendar, there will be a US consumer confidence reading at 1500 GMT.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
15 May 2024 14:29

Abingdon pregnancy self-tests now available under the Boots brand

(Alliance News) - Abingdon Health PLC on Wednesday said its saliva pregnancy self test is now available across the UK and online.

Read more
15 May 2024 13:00

Abingdon Health launching saliva pregnancy test with Boots

(Sharecast News) - Lateral flow contract development and manufacturing organisation Abingdon Health announced the launch of Boots' own-brand saliva pregnancy self-test across the UK and online on Wednesday, in collaboration with Salignostics and Crest Medical.

Read more
7 May 2024 20:22

TRADING UPDATES: Abingdon Health buys IVDeology Holdings

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
7 May 2024 13:20

Abingdon Health acquires IVDeology in £0.7m deal

(Sharecast News) - Lateral flow contract research, development and manufacturing provider Abingdon Health announced the acquisition of IVDeology and its subsidiaries on Tuesday, for up to £0.7m.

Read more
25 Mar 2024 15:27

Abingdon Health progresses at-home STD test programme

(Sharecast News) - Abingdon Health updated the market on the development of self-tests for sexually transmitted diseases (STDs) on Monday, announcing the completion of the 'design freeze' stage for four key tests in collaboration with Devyn.

Read more
25 Mar 2024 13:51

TRADING UPDATES: Peel Hunt's RetailBook raises GBP2.5 million

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
20 Mar 2024 11:00

Abingdon Health to launch two Boots-branded self-tests

(Sharecast News) - Lateral flow test specialist Abingdon Health announced a partnership with Crest Medical on Wednesday, to introduce Boots' own-brand rapid self-tests across the UK and online.

Read more
20 Mar 2024 10:26

Abingdon Health strikes deal amidst upswing in self testing market

(Alliance News) - Abingdon Health PLC announced on Wednesday that it will provide Boots UK Ltd with rapid lateral flow self-tests to be sold under the Boots own brand label.

Read more
20 Mar 2024 09:55

AIM WINNERS & LOSERS: Abingdon Health rises on Boots agreement

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
14 Mar 2024 15:17

EARNINGS AND TRADING: Smarttech247 and Beeks in deal boosts

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
14 Mar 2024 11:20

AIM WINNERS & LOSERS: Smartspace backs Sign In bid; Abingdon jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
14 Mar 2024 09:03

LONDON MARKET OPEN: London stocks tread water with US data to come

(Alliance News) - Stocks in London barely budged after the opening bell on Thursday, after a largely softer session in New York overnight, as eyes turn to a batch of US data and what it can mean for Federal Reserve interest rates.

Read more
11 Jan 2024 12:06

Abingdon Health shares down despite decent interim results

(Alliance News) - Abingdon Health PLC on Thursday said that it remains confident in its near-term prospects, and will focus on revenue growth and cost-cutting as it looks to swing to profit.

Read more
15 Dec 2023 11:18

Abingdon Health upbeat on strong recent progress

(Sharecast News) - Lateral flow contract research, development and manufacturing organisation Abingdon Health reported solid progress on Friday as it held its annual general meeting.

Read more
15 Dec 2023 10:37

IN BRIEF: Abingdon expects higher half-year revenue

Abingdon Health PLC - York, England-based lateral flow test contract development and manufacturing company - Ahead of its annual general meeting on Friday morning, says revenue for the six months to December 31 will be "significantly higher" than GBP1.1 million a year ago. Adds that it remains "hugely focused" on continuing to grow revenue and reduce its cash-burn throughout the year ending June 30.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.